when injecting semaglutide Injection Sites: Best Locations & Doctor Advice The Beneficial Side Effects of

Similarly, Mounjaro is FDA-approved for diabetes, while its twin drug Zepbound is approved for obesity

Tirzepatide has shown promising results in weight loss, although it's primarily used for managing type 2 diabetes

In that trial, participants with type 2 diabetes on the highest dose achieved: Average HbA1c reduction of 2.02 percentage points Average weight loss of 16.9% over 36 weeks A high proportion of participants reaching HbA1c below 7%, which is the standard clinical target The weight loss in the diabetes population was lower than in the non-diabetes population, which is consistent with what we see across all GLP-1 class drugs

Provider access: How easy is it to reach a healthcare provider for questions

Nausea showed up around weeks six and seven, mostly in the evenings